Background: Obstructive sleep apnea (OSA) is associated with metabolic dysfunction and increased cardiovascular risk. Lectin-like oxidized LDL receptor-1 (LOX-1) and lipoprotein(a) [LPA] are emerging biomarkers implicated in atherosclerosis. We aimed to evaluate their association with OSA severity and metabolic parameters. Methods: In this case-control study, 90 participants were enrolled (60 OSA patients, 30 controls). Anthropometric, biochemical, and polysomnographic (PSG) parameters were recorded. LOX-1 and LPA levels were measured and compared between groups. Correlation, linear regression, and logistic regression analyses were performed to determine associations and independent predictors. Results: OSA patients were older (median 50 vs 39 years, p<0.001) and had significantly higher BMI (33.45±5.01 vs 24.14±2.90 kg/m², p<0.001) and neck circumference (p<0.001). HDL was lower, while LDL, fasting glucose, and HbA1c were significantly higher in OSA (p<0.01). LOX-1 levels were significantly elevated in OSA compared to controls (p<0.001), whereas LPA levels did not differ significantly. LOX-1 showed a positive correlation with triglycerides (ρ=0.44, p<0.001) but not with AHI or other PSG parameters. LPA showed no significant correlation with metabolic or PSG variables. In a detailed analysis, LOX-1, age, and BMI were found to be independently related to OSA, meaning that higher levels of these factors increase the likelihood of having the condition. Conclusion: LOX-1 is higher in OSA and linked to the disease, while LPA is not, indicating that LOX-1 might help assess the risk of heart and metabolic